最新ニュース KE Holdings (NYSE:BEKE) 株価情報

KE Holdings

KE Holdings, or Beike, is a large residential real estate sales and rental brokerage company in China. Founded in 2001, the company operates through self-owned Lianjia stores in Beijing and Shanghai and connected third-party agencies including franchise brand Deyou in other cities, with commissions charged on existing-home and new-home transactions. Leveraging an online-offline hybrid model, Beike also attract clients through its namesake online marketplace. The company tapped into home renovation services by acquiring Shengdu Home Decoration in 2022. As of the end of 2023, Beike's cofounders collectively control the company, while Tencent and its affiliates share 8% of voting power.

KE Holdings Inc American Depositary Shares (each representing three Class A Ordinary Shares)

KE Holdings Inc

Bekem Metals Inc

Expedia Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) has outperformed the market over the past 15 years by 3.5% on an annualized basis producing an average annual return of 15.34%. Currently, Expedia Group has a market capitalization of $25.26 billion. 
Buying $1000 In EXPE: If an investor had bought $1000 of EXPE stock 15 years ago, it would be worth $8,849.37 today based on a price of $196.81 for EXPE at the time of writing.
<h3>Expedia Group's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740172510_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

EXPE

Here's How Much You Would Have Made Owning Expedia Group Stock In The Last 15 Years

As previously disclosed in a Current Report on Form 8-K filed by TransMedics Group, Inc. (the "Company") on September&nbsp;5, 2023, a Current Report on Form 8-K filed by the Company on September&nbsp;12, 2023, a Current Report on Form 8-K filed by the Company on September&nbsp;22, 2023, a Current Report on Form 8-K filed by the Company on November&nbsp;13, 2023, a Current Report on Form 8-K filed by the Company on December&nbsp;19, 2023, a Current Report on Form 8-K filed by the Company on January&nbsp;2, 2024, a Current Report on Form 8-K filed by the Company on January&nbsp;29, 2024, a Current Report on Form 8-K filed by the Company on February&nbsp;6, 2024, a Current Report on Form 8-K filed by the Company on March&nbsp;12, 2024, a Current Report on Form 8-K filed by the Company on July&nbsp;2, 2024, a Current Report on Form 8-K filed by the Company on July&nbsp;29, 2024, a Current Report on Form 8-K filed by the Company on September&nbsp;11, 2024, a Current Report on Form 8-K filed by the Company on December&nbsp;9, 2024, and a Current Report on Form 8-K filed by the Company on January&nbsp;14, 2025 (together, the "Prior Reports"), TransMedics, Inc. (the "Buyer"), a Delaware corporation and wholly-owned subsidiary of the Company, acquired 20 fixed-wing aircraft (collectively, the "Prior Acquisitions") as more specifically described in the Prior Reports.
Subsequently, on February&nbsp;20, 2025, the Buyer acquired a fixed-wing aircraft from Ocean Select Seafood, L.L.C. for a purchase price of approximately $14.3&nbsp;million (together with the Prior Acquisitions, the "Acquisitions"). The Company intends to use each of the 21 aircraft it has acquired to date to transport donor organs as part of the services offered under the Company's National OCS Program, and for purposes of this Current Report on Form 8-K the Company considers the Acquisitions to be a series of related transactions with respect to the acquisition of a fleet of aircraft for use in the Company's National OCS Program.

TMDX

TransMedics Acquires Fixed-Wing Aircraft From Ocean Select Seafood For $14.3M; Total Of 21 Aircraft To Transport Donor Organs For National OCS Program

Barrington Research analyst Gary Prestopino maintains Openlane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAR#NYSE">KAR</a>) with a Outperform and maintains $25 price target.

Price Target

Analyst Ratings

Barrington Research Maintains Outperform on Openlane, Maintains $25 Price Target

WIIM

Hawaiian Electric shares are trading lower after the company reported a Q4 Eps miss.

eXoZymes Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXOZ#NASDAQ">EXOZ</a>, formerly Invizyne Technologies))) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, medicines, and biofuels - and MDB Capital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDBH#NASDAQ">MDBH</a>) - a premier venture platform for breakthrough technology companies - today announced key leadership changes within the eXoZymes board of directors.
Mo Hayat has transitioned out of his roles as Chairman of the Board and President of eXoZymes, to focus on new MDB Capital ventures. Edgardo Rayo will join the board on behalf of MDB Capital, making it a full circle moment, as he was the MDB Capital team member who discovered the team of scientific co-founders at UCLA and recognized the transformative potential of the science that ultimately evolved into eXoZymes.
Christopher Marlett, CEO of MDB Capital and a current board member of eXoZymes, will assume the role of Chairman to ensure the help and support that MDB Capital will continue to provide eXoZymes.

Management

EXOZ

MDBH

eXoZymes Announces Mo Hayat Has Transitioned Out Of His Roles As Chairman Of The Board And President Of EXoZymes, To Focus On New MDB Capital Venture; Christopher Marlett To Assume The Role Of Chairman

Earnings

Hawaiian Electric Indus Q4 EPS $(0.40) Down From $0.44 YoY, Sales $799.18M Down From $853.42M YoY

Wall Street eased from record highs after Walmart's weak outlook raised concerns about consumer spending and economic growth, while investors also assessed signals from the Federal Reserve <a href="https://www.benzinga.com/news/earnings/25/02/43869433/walmart-expects-slower-growth-in-an-uncertain-time-cfo-says-on-earnings-call">and trade policy uncertainties.</a>
Minutes from the latest Fed meeting confirmed a cautious stance. Officials stressed the need for more evidence that inflation had cooled before considering rate cuts. Several policymakers suggested that rates could stay high if economic conditions remained <a href="https://www.benzinga.com/25/02/43829352/fomc-minutes">strong and inflation persisted.</a>
They also cited inflation risks from potential shifts in trade and immigration policies, supply chain disruptions due to geopolitical tensions and stronger-than-expected consumer spending.
Earlier in the week, President Donald Trump announced plans to impose a 25% tariff on imports of autos, semiconductors and pharmaceuticals, set to take effect on April 2, heightening trade uncertainty, particularly for multinational companies reliant <a href="https://www.benzinga.com/25/02/43805852/trump-shakes-global-trade-with-25-auto-chip-and-pharma-tariffs-announcement-asian-stocks-pare-their-five-day-rally">on global supply chains</a>.
Also Read: <a href="https://www.benzinga.com/etfs/specialty-etfs/25/02/43893016/rising-inflation-in-japan-3-etfs-to-watch-as-boj-navigates-rate-hike-expectations">Rising Inflation In Japan: 3 ETFs To Watch As BOJ Navigates Rate Hike Expectations</a>
On Tuesday, U.S. officials, led by Secretary of State Marco Rubio, met with Russian representatives, headed by Foreign Minister Sergey Lavrov, in Saudi Arabia to initiate discussions on ending <a href="https://www.benzinga.com/news/global/25/02/43787369/us-russian-officials-begin-ukraine-peace-talks-defense-sector-stocks-rise">the war in Ukraine.</a> Ukrainian President Volodymyr Zelenskyy reiterated that his country will not accept any peace agreement negotiated without its direct participation. Notably, no European representatives attended talks in Saudi Arabia.
Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) — the S&amp;P 500's top performer in 2024 — plunged after reports indicated that the Pentagon, one of its largest clients, was preparing <a href="https://chatgpt.com/c/67b88100-a1d8-8007-b054-fe4bc320e8ac">for deep budget cuts.</a> Investor concerns grew further after CEO Alex Karp disclosed plans to sell nearly 10 million shares over the next six months.
Chinese technology stocks surged on Friday, led by Alibaba Group Holding Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), which spiked after delivering strong earnings and upbeat guidance. Optimism also rose amid speculation that China's central bank could ease monetary policy, alongside new fiscal stimulus measures from policymakers after the annual parliamentary meeting in early March.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/25/02/43893285/warren-buffetts-annual-shareholder-letter-arrives-saturday-could-investors-get-updates-on-apple-succession-new-investments">Warren Buffett&#8217;s Annual Shareholder Letter Arrives Saturday: Could Investors Get Updates On Apple, Succession, New Investments?</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Econ #s

Federal Reserve

BABA

PLTR

Walmart's Warning, Fed Highlights Inflation Risks, Chinese Stocks Surge: This Week In Markets

NAVI

Navient Finalizes Sale Of Government Services Business To Gallant Capital Partners; 1,200 Employees Transferred; Terms Not Disclosed

Offerings

Canaan Files For Mixed Shelf; Size Not Disclosed

Biotech

General

CODX

Co-Diagnostics Withdraws 510(k) Application For Co-Dx PCR COVID-19 Test After FDA Dialogue, Plans Enhanced Version Submission

Across the recent three months, 5 analysts have shared their insights on Elanco Animal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELAN#NYSE">ELAN</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $16.0, a high estimate of $18.00, and a low estimate of $14.00. Highlighting a 9.45% decrease, the current average has fallen from the previous average price target of $17.67. 
<img src="https://www.benzinga.com/files/images/story/2025/1740171655_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Elanco Animal Health. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jonathan Block</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$16.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Erin Wright</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$14.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Jonathan Block</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$18.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Andrea Alfonso</td>
<td>UBS</td>
<td>Announces</td>
<td>Buy</td>
<td>$18.00</td>
<td>-</td>
</tr>
<tr>
<td>Daniel Clark</td>
<td>Leerink Partners</td>
<td>Announces</td>
<td>Market Perform</td>
<td>$14.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Elanco Animal Health. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Elanco Animal Health compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Elanco Animal Health's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Elanco Animal Health's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ELAN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Elanco Animal Health analyst ratings.</a>
<h2>Delving into Elanco Animal Health's Background</h2>
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
<h3>Elanco Animal Health: A Financial Overview</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Decline in Revenue: Over the 3 months period, Elanco Animal Health faced challenges, resulting in a decline of approximately -3.56% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Elanco Animal Health's net margin is impressive, surpassing industry averages. With a net margin of 35.34%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Elanco Animal Health's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 5.84%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.69%, the company showcases effective utilization of assets.
Debt Management: Elanco Animal Health's debt-to-equity ratio is below the industry average at 0.67, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ELAN

Beyond The Numbers: 5 Analysts Discuss Elanco Animal Health Stock

<a href="https://patentcenter.uspto.gov/applications/18588114/ifw/docs" title="https://patentcenter.uspto.gov/applications/18588114/ifw/docs">https://patentcenter.uspto.gov/applications/18588114/ifw/docs</a>

DGLY

Digital Ally Has Received A Notice Of Allowance For A U.S. Patent Titled "VIDEO RECORDING MANAGER DEVICE AND SYSTEM FOR REDUNDANT MOBILE VIDEO RECORDING".

In the latest quarter, 5 analysts provided ratings for CarGurus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARG#NASDAQ">CARG</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $44.2, with a high estimate of $46.00 and a low estimate of $42.00. This upward trend is apparent, with the current average reflecting a 2.31% increase from the previous average price target of $43.20.
<img src="https://www.benzinga.com/files/images/story/2025/1740171646_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A clear picture of CarGurus's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nicholas Jones</td>
<td>Citizens Capital Markets</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$43.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Rajat Gupta</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$42.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Chris Pierce</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$45.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Chris Pierce</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$45.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Nicholas Jones</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$46.00</td>
<td>$46.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CarGurus. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of CarGurus compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of CarGurus's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of CarGurus's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CARG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on CarGurus analyst ratings.</a>
<h2>Unveiling the Story Behind CarGurus</h2>
CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listing through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments namely U.S. Marketplace and Digital Wholesale. It generates majority of revenue from the U.S. Marketplace.
<h3>A Deep Dive into CarGurus's Financials</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: CarGurus displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 5.44%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Communication Services sector.
Net Margin: CarGurus's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.73% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): CarGurus's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 4.81%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): CarGurus's ROA stands out, surpassing industry averages. With an impressive ROA of 2.94%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: CarGurus's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.39.
<h2>The Basics of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CARG

Analyst Expectations For CarGurus's Future

Across the recent three months, 6 analysts have shared their insights on TD Synnex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $148.33, a high estimate of $165.00, and a low estimate of $140.00. Surpassing the previous average price target of $134.83, the current average has increased by 10.01%.
<img src="https://www.benzinga.com/files/images/story/2025/1740171637_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of TD Synnex among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$165.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$140.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Joseph Cardoso</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$150.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Tim Long</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$148.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Shreya Gheewala</td>
<td>CFRA</td>
<td>Raises</td>
<td>Buy</td>
<td>$147.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$140.00</td>
<td>$140.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to TD Synnex. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of TD Synnex compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of TD Synnex's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of TD Synnex's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/SNX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on TD Synnex analyst ratings.</a>
<h2>Get to Know TD Synnex Better</h2>
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.
<h3>Unraveling the Financial Story of TD Synnex</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Positive Revenue Trend: Examining TD Synnex's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 9.98% as of 30 November, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: TD Synnex's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 1.22%, the company may face hurdles in effective cost management.
Return on Equity (ROE): TD Synnex's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.38%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.65%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: TD Synnex's debt-to-equity ratio is below the industry average at 0.49, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>How Are Analyst Ratings Determined?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: TD Synnex In The Eyes Of 6 Experts

Across the recent three months, 10 analysts have shared their insights on CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $513.3, with a high estimate of $640.00 and a low estimate of $373.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 9.47%. 
<img src="https://www.benzinga.com/files/images/story/2025/1740171628_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of CACI International among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Akers</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$536.00</td>
<td>$503.00</td>
</tr>
<tr>
<td>Brian Gesuale</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$490.00</td>
<td>$475.00</td>
</tr>
<tr>
<td>Sheila Kahyaoglu</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Buy</td>
<td>$515.00</td>
<td>-</td>
</tr>
<tr>
<td>Gautam Khanna</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Buy</td>
<td>$480.00</td>
<td>$610.00</td>
</tr>
<tr>
<td>Matthew Akers</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$503.00</td>
<td>$564.00</td>
</tr>
<tr>
<td>Brian Gesuale</td>
<td>Raymond James</td>
<td>Announces</td>
<td>Outperform</td>
<td>$475.00</td>
<td>-</td>
</tr>
<tr>
<td>Peter Arment</td>
<td>Baird</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$640.00</td>
<td>$640.00</td>
</tr>
<tr>
<td>Gavin Parsons</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$373.00</td>
<td>$540.00</td>
</tr>
<tr>
<td>Gavin Parsons</td>
<td>UBS</td>
<td>Announces</td>
<td>Buy</td>
<td>$557.00</td>
<td>-</td>
</tr>
<tr>
<td>Matthew Akers</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$564.00</td>
<td>$637.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to CACI International. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of CACI International compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for CACI International's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into CACI International's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CACI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on CACI International analyst ratings.</a>
<h2>All You Need to Know About CACI International</h2>
CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.
<h3>Financial Insights: CACI International</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: CACI International displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 14.5%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: CACI International's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 5.24%, the company may face hurdles in effective cost management.
Return on Equity (ROE): CACI International's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 2.98%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): CACI International's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.4%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: CACI International's debt-to-equity ratio is below the industry average at 0.92, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>What Are Analyst Ratings?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CACI

Beyond The Numbers: 10 Analysts Discuss CACI International Stock

Quad/Graphics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QUAD#NYSE">QUAD</a>) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $10.15, a high estimate of $10.30, and a low estimate of $10.00. This current average has increased by 6.84% from the previous average price target of $9.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1740171620_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A clear picture of Quad/Graphics's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kevin Steinke</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$10.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Barton Crockett</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$10.30</td>
<td>$10.30</td>
</tr>
<tr>
<td>Kevin Steinke</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$10.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Barton Crockett</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$10.30</td>
<td>$7.70</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Quad/Graphics. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Quad/Graphics compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Quad/Graphics's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Quad/Graphics's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/QUAD/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Quad/Graphics analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Discovering Quad/Graphics: A Closer Look</h2>
Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market.
<h3>Quad/Graphics's Financial Performance</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Quad/Graphics displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 4.98%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Quad/Graphics's net margin excels beyond industry benchmarks, reaching 0.66%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Quad/Graphics's ROE stands out, surpassing industry averages. With an impressive ROE of 9.33%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Quad/Graphics's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.35%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Quad/Graphics's debt-to-equity ratio surpasses industry norms, standing at 9.31. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: Simplified</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

QUAD

What Analysts Are Saying About Quad/Graphics Stock

In the last three months, 4 analysts have published ratings on GDS Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>), offering a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $35.0, along with a high estimate of $53.00 and a low estimate of $26.00. Witnessing a positive shift, the current average has risen by 36.35% from the previous average price target of $25.67.
<img src="https://www.benzinga.com/files/images/story/2025/1740171613_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The perception of GDS Holdings by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Frank Louthan</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$53.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Jonathan Atkin</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$26.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Greg Miller</td>
<td>JMP Securities</td>
<td>Announces</td>
<td>Market Outperform</td>
<td>$35.00</td>
<td>-</td>
</tr>
<tr>
<td>Jonathan Atkin</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$26.00</td>
<td>$26.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to GDS Holdings. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of GDS Holdings compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of GDS Holdings's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of GDS Holdings's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/GDS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on GDS Holdings analyst ratings.</a>
<h2>Get to Know GDS Holdings Better</h2>
GDS Holdings started as an IT service provider in 2001 then moved to the data center business with its first self-developed data center opening in 2010. The company now develops and operates data centers in China and also builds, operates and transfers data centers for other clients. It offers colocation and managed services and mainly targets hyperscale cloud service customers who take large areas of its data centers or even whole data centers under long-term contracts. It has aggressively raised capital over the past four years for expansion. Its data centers are located predominantly in and around the Tier 1 cities in China and it has also started an expanding into Southeast Asia. GDS listed on the Nasdaq in 2016 and completed a secondary listing in Hong Kong in 2020.
<h3>GDS Holdings's Financial Performance</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: GDS Holdings's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 17.73%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: GDS Holdings's net margin is impressive, surpassing industry averages. With a net margin of -6.94%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): GDS Holdings's ROE stands out, surpassing industry averages. With an impressive ROE of -1.11%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): GDS Holdings's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -0.26%, the company showcases efficient use of assets and strong financial health.
Debt Management: GDS Holdings's debt-to-equity ratio surpasses industry norms, standing at 2.73. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: What Are They?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

4 Analysts Have This To Say About GDS Holdings

Texas Roadhouse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXRH#NASDAQ">TXRH</a>) has outperformed the market over the past 10 years by 5.18% on an annualized basis producing an average annual return of 16.18%. Currently, Texas Roadhouse has a market capitalization of $11.45 billion. 
Buying $100 In TXRH: If an investor had bought $100 of TXRH stock 10 years ago, it would be worth $448.55 today based on a price of $171.63 for TXRH at the time of writing.
<h3>Texas Roadhouse's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740171611_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TXRH

$100 Invested In Texas Roadhouse 10 Years Ago Would Be Worth This Much Today

$BTC

Bitcoin is trading lower amid risk-off sentiment due to weaker US consumer sentiment.

Luigi Mangione was<a href="https://www.benzinga.com/news/legal/25/02/43887520/luigi-mangione-back-in-court-friday-supporters-donate-500k-to-suspected-killer"> back in court</a> Friday for an update on the state charges against him in connection with the killing of UnitedHealthcare CEO Brian Thompson.
What Happened: Friday marked Mangione's first court date since December, when he <a href="https://www.benzinga.com/24/12/42655562/luigi-mangione-suspected-ceo-assassin-pleads-not-guilty-in-new-york-court">pleaded not guilty</a> to state charges. The suspected killer also faces federal charges, with the potential of the death penalty if convicted. 
Mangione's lawyer Karen Friedman Agnifilo called out several parties who appeared in a recent HBO true crime documentary on the Mangione case. Agnificlo said New York City Mayor Eric Adams and NYPD Chief of Detectives Joseph Kenny appeared on the documentary. HBO is a unit of Warner Bros. Discovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>).
"My shock that the chief of detectives of the NYPD along with the NYC mayor had time to sit down with HBO and put hair and makeup and….talk about their theories of the case," Agnifilo said, as reported by <a href="https://www.newsweek.com/luigi-mangione-court-live-updates-suspect-face-murder-terror-charges-2034323#live-blog-46395">Newsweek</a>.
Mangione's lawyer said that his "right to a fair trial is continuously being impacted." His lawyer cited the Pennsylvania arrest at a McDonald's and said his client&#8217;s constitutional rights were violated there as well.
"I think there's a very serious search issue in this matter."
While discussing evidence in the case, Agnifilo said the defense team has not received the bulk of the discovery including police records, phone records or he so-called manifesto found on Mangione at the time of his arrest.
Items like DNA and forensic testing, policy body cam footage, witness statements and the autopsy report were turned over Friday, according to the report.
Judge Gregory Carro also said Mangione was to remain handcuffed during Friday's trial for his safety, something his lawyer took exception with and wanted on the record.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Luigi Mangione just now arriving at the New York Supreme Criminal Court for his first court appearance of the year. <a href="https://t.co/p2bfevDMbs">pic.twitter.com/p2bfevDMbs</a>
&mdash; The Luigi Case (@LuigiCaseFiles) <a href="https://twitter.com/LuigiCaseFiles/status/1893019502985564577?ref_src=twsrc%5Etfw">February 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Also: <a href="https://www.benzinga.com/news/legal/24/12/42418763/unitedhealthcare-ceo-murder-suspect-chronic-pain-unabomber-fascination-isolation-details-emerge">UnitedHealthcare CEO Murder Suspect: Chronic Pain, Unabomber Fascination, Isolation Details Emerge</a>
Why It's Important: The judge did not provide an update on the trial timeline in the case Friday. Mangione did not speak during Friday's hearing.
Mangione also faces federal charges that could include a death penalty sentence upon conviction. The accused killer has not yet entered a plea for the federal charges. Mangione's next court hearing on the federal charges is scheduled for March 19, according to the report.
A large group of supporters of the suspected killer were spotted outside the courtroom and inside the public gallery during Friday's trial. Some supporters had signs that read "patients before profits" and "Free Luigi."
A legal defense fund for Mangione has raised over $514,000 in donations through Friday, as reported by the New York Post. The funds are said to help pay Mangione's legal fees as he recently beefed up his legal team.
The online fundraiser reached its previous target and now has its sights set on raising $1 million.
Mangione thanked people for his support in his first statement from prison last week. 
"I am overwhelmed by – and grateful for – everyone who has written me to share their stories and express their support," Mangione's statement said.
UnitedHealthcare, which is owned by UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), is the largest individual player in Medicare Advantage with 7.8 million members, the company's latest earnings report revealed. The company also has 4.3 million members enrolled in Medicare supplement plans through UnitedHealthcare. It also has 3 million people enrolled in standalone Part D coverage.
The company is now the subject of a Department of Justice investigation over its Medicare billing practices, which was <a href="https://www.benzinga.com/25/02/43879859/doj-investigates-unitedhealth-probe-accuses-of-inflating-medicare-diagnoses">announced Friday morning</a>.
UNH Price Action: UnitedHealth stock is down 7.3% to $465.60 on Friday versus a 52-week trading range of $436.38 to $630.73. The stock is down 11% over the last year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/12/42544499/luigi-mangione-documentaries-in-the-works-from-award-winning-creators-and-possibly-rapper-50-cent">Luigi Mangione Documentaries In The Works From Award-Winning Creators — And Possibly Rapper 50 Cent</a></li>
</ul>
Luigi Mangione, who is charged in connection with the murder of UnitedHealthcare&#8217;s CEO. Photo via the Pennsylvania State Police.

Legal

Movers

Media

Luigi Mangione Lawyer Says 'Right To A Fair Trial' Compromised, Supporters Show Up To Court

Press Releases

KE Holdings Inc. Releases 2023 Environmental, Social and Governance Report

KE Holdings Inc. Files Its Annual Report on Form 20-F

KE Holdings Inc. to Report First Quarter 2024 Financial Results on May 23, 2024 Eastern Time

KE Holdings Inc. Announces First Quarter 2024 Unaudited Financial Results

KE Holdings Inc. Announces Results of Annual General Meeting

KE Holdings Inc. to Report Second Quarter 2024 Financial Results on August 12, 2024 Eastern Time

KE Holdings Inc. Announces Second Quarter 2024 Unaudited Financial Results and Upsizing and Extension of Share Repurchase Program

KE Holdings Inc. Announces Upsizing and Extension of Share Repurchase Program

KE Holdings Inc. to Report Third Quarter 2024 Financial Results on November 21, 2024 Eastern Time

Comments

KE Holdings

ニュース

最新ニュース KE Holdings (NYSE:BEKE) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル